Autotransplantation and Enamel Matrix Derivatives Case Series
ATTCS
Efficacy of Digitally Tooth Autotransplantation With Adjunctive Use of Enamel Matrix Derivatives (EMD): A Prospective Case Series
1 other identifier
interventional
14
1 country
2
Brief Summary
The goal of this prospective case series is to compare the adjunctive use of enamel matrix derivatives in the treatment of tooth autotransplantation in terms of clinical attachment level. The main question it aims to answer is: \- What is the benefit, in terms of clinical attachment level, of using enamel matrix derivatives adjunctive to tooth autotransplantation? Participants will be subjected to a digitally protocol of tooth autotransplantation.Only one group (test) is assessed. It will be supplemented with the application of enamel matrix derivatives before the placement of the transplanted tooth into the surgically produced alveolus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedFirst Submitted
Initial submission to the registry
January 30, 2024
CompletedFirst Posted
Study publicly available on registry
February 15, 2024
CompletedFebruary 15, 2024
February 1, 2024
3.3 years
January 30, 2024
February 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinical attachment level (CAL)
CAL level changes on the donor tooth between the baseline situation and the last follow up visit.
through study completion, an average of 1 year
Study Arms (1)
ATT + EMD
EXPERIMENTALThere is only 1 arm, autotransplantation (ATT) + adjunctive EMD
Interventions
All surgical treatments will be performed by the same experienced periodontist (IP) after the administration of local anesthesia. Initially, tooth sectioning of the hopeless tooth (receptor) will be carried out using fissure carbide burs, and the remaining fragments will be extracted as minimally invasively as possible. A tooth-supported surgical guide will be used to prepare the recipient site following the 3D planning. Additional alveoloplasty procedures will be performed with round diamond burs if necessary to adapt the CARP model to the virtual planning position. The donor tooth will be extracted as atraumatically as possible, utilizing a piezoelectric surgical instrument if osteotomy is required, and avoiding the use of elevators or forceps over the root surface. Extraorally, EMD will be applied to the root surface of the donor tooth
Eligibility Criteria
You may qualify if:
- adults (≥18 years old) capable of providing informed consent, teeth deemed unrestorable and in need of replacement
- presence of a viable, healthy, periodontally stable, and nonfunctional tooth (e.g., third molar) suitable for autotransplantation
- periodontally healthy individuals or those with stable periodontal conditions after periodontal therapy.
You may not qualify if:
- clinical attachment loss of the donor teeth
- compromised general health or patients with systemic diseases that could influence the therapy outcome (uncontrolled diabetes mellitus, bone disorders, etc.)
- pregnant or nursing women
- chronic use of corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or immune-modulator drugs
- patients requiring medications that affect bone metabolism (bisphosphonates)
- chronic oral mucosa diseases
- evident signs of severe bruxism or clenching habits
- smokers of more than 10 cigarettes per day
- non-compliant patients with 25% plaque index at the time of re-evaluation after non-surgical periodontal therapy and oral hygiene instructions
- patients unable to attend study-related procedures and follow-up visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Universidad Complutense de Madrid
Madrid, 28003, Spain
Universidad Complutense Madrid
Madrid, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ignacio Pedrinaci, DDS
Universidad Complutense de Madrid
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Principal investigator
Study Record Dates
First Submitted
January 30, 2024
First Posted
February 15, 2024
Study Start
June 1, 2020
Primary Completion
September 1, 2023
Study Completion
December 1, 2023
Last Updated
February 15, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share